NR4A1 and lung cancer: On the other hand, NR4A1 is commonly overexpressed in lung cancer patients and correlates to poor prognosis [30], and it has been shown to confer a proliferative advantage to colon cancer cells as well as increasing the invasive behavior of breast cancer by enhancing TGFβ signaling [31], [32].